Skip to content

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation

Optimizing Quality of Life by Improved Patient Expectation Following Atrial Fibrillation Catheter Ablation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05557526
Enrollment
60
Registered
2022-09-28
Start date
2022-06-09
Completion date
2027-12-01
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

The aim is to investigate whether optimizing patients' expectations towards the interventional treatment of atrial fibrillation (catheter ablation) leads to a lower disease-related impairment of the patients compared to the control group in the first three months after ablation (the so-called blanking period).

Interventions

OTHERExpectation optimization

A short (2-5 min) verbal intervention will be createad individually based on the expectation of the patient towards the procedure.

Sponsors

Evangelical Hospital Düsseldorf
Lead SponsorOTHER
University Hospital, Essen
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* symptomatic atrial fibrillation * indication for pulmonary vein isolation * sufficient command of the German language

Exclusion criteria

* age \<18 years * permanent atrial fibrillation * presence of psychiatric disorders which impair the study participitatin * presence of another medical condiction which influences quality of life stronger than the cardiac condition * atrial fibrillation induced by intoxication, medicamentation or infection * inability to grap the course of the study

Design outcomes

Primary

MeasureTime frameDescription
Quality of life (questionaire)3 monthsQuality of life of life will be compared between groups and between different time points (before versus 3 months after ablation) with "the atrial fibrillation effect on quality-of-life (AFEQT) questionnaire". An overall AFEQT score ranges from 0 to 100. A score of 0 corresponds to complete disability (or responding "extremely" limited, difficult or bothersome to all questions answered), while a score of 100 corresponds to no disability (or responding "not at all" limited, difficult or bothersome to all questions answered). Therefore, a positive change in score corresponds to improvement in AF symptoms.

Secondary

MeasureTime frameDescription
Recurrence of atrial arrhythmias3 monthsElectrocardiographic documentation of any atrial arrhythmia with a duration \>30 sec
Autonomic function (heart rate variability measurement)3 monthsAutonomic function will be assessed by heart rate variability measurement (low frequency and high frequency domain, root mean square of successive differences) to compare patients between groups and time points (before versus 3 months after ablation)
Atrial volume [ml/m2]3 monthsAtrial volume measured via echocardiography will be compared between groups and time points (before versus 3 months after ablation)
Left ventricular ejection fraction [%]3 monthsLeft ventricular ejection fraction measured via echocardiography will be compared between groups and between time points (before versus 3 months after ablation)
Inflammatory markers from blood samples3 monthsInflammatory markers (including IFN-gamma, TNF-alpha TGF-beta, IL-1beta, IL-4, IL-6, IL-8, IL-10, IL-1, CRP, MPO, NGF, S100B, ANP, FABP4) in blood samples measured via enzyme-linked immunosorbent assays will be compared between groups and between time points (before versus 3 months after ablation)
Treatment expectations (questionaire)3 months, 12 monthsTreatment expectations will be measured using the GEEE (Generic rating scale for previous treatment experiences, treatment expectations, and treatment effects) questionaire by Rief et al. and compared between groups and between time points (before versus 3 months after ablation / before versus 12 months after ablation). The subscale Generic rating scale for treatment expectations consists of three items that assess expectations towards treatment on a numeric rating scale with eleven response options (0-10); total scores of all three subscales combined range from 0-30 with higher scores indicating higher treatment expectations.
Physical Activity (questionaire)3 months, 12 monthsPhysical activity will be measured will be compared between groups and time points (before versus 3 months after ablation) using the short version of the International Physical Activity Questionnaire (IPAQ - short). The short version of the IPAQ is a 7-item questionnaire that assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives. Open-ended questions surrounding individuals' last 7-day recall of physical activity are considered to estimate total physical activity min/week and time spent sitting. Interpretation: Three levels (categories) of physical activity are proposed: low, moderate and high.
General quality of life (questionaire)3 months, 12 monthsGeneral quality of life of life will be compared between groups and between different time points (before versus 3 months after ablation) with "F-36 questionaire. SF-36 is a multi-domain instrument with 36 items to evaluate the health status and quality of life. It included 8 subscales (physical functioning, physical role functioning, bodily pain, general health perception, vitality, social functioning, emotional role functioning, and mental health), which yielded a Physical Component Summary (PCS) with score range 0-100 (higher score-better quality of life) and a Mental Component Summary (MCS) with score range 0-100 (higher score-better quality of life) in addition to subscale scores. The PCS scores are normalized to a mean of 50 and standard deviations of 10, based upon general US population norms. A positive change indicates improvement while a negative change indicates worsening of health status and quality of life.
Hospital Anxiety and Depression Scale HADS (questionaire)3 months, 12 monthsHospital anxiety and depression will becompared between groups and time points (before versus 3 months after ablation) using the Hospital Anxiety and Depression Scale (HADS). It consists of 14 items rated zero to three on Likert scales, allowing computation of sub-scores for depression and anxiety symptoms. Subscores as well as total sum score will be applied.
Cardiac Anxiety Questionnaire CAQ (questionaire)3 months, 12 monthsCardiac anxiety will becompared between groups and time points (before versus 3 months after ablation) using the established Cardiac Anxiety Questionnaire CAQ to determine cardiac anxiety, fear, avoidance and attention. The score ranges between 0 and 68 for the German version, with a greater score indicating elevated cardiac anxiety.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 29, 2026